Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1I | Q9P0X4 | 9/20 | 0.51 |
| ▸ | CACNA1G | O43497 | 8/20 | 0.51 |
| ▸ | CACNA1H | O95180 | 7/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3439964 | 0.86 | CACNA1G (0.64) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL7895013 | 0.86 | CACNA1G (0.49) | CACNA1ICACNA1GCACNA1HMAPTSMN1; SMN2 | |
| SCHEMBL3439966 | 0.85 | CACNA1G (0.50) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL2113322 | 0.85 | MAPT (0.58) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL16118387 | 0.83 | KMT2A (0.67) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL3439967 | 0.82 | STIM1 (0.53) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL18593147 | 0.81 | CACNA1I (0.72) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL3439983 | 0.80 | STIM1 (0.49) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL15154590 | 0.80 | LMNA (0.44) | CACNA1ICACNA1GCACNA1HMAPTTSHR | |
| SCHEMBL759248 | 0.80 | STIM1 (0.66) | CACNA1ICACNA1GMAPTTSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399436-B2 | N-pyrazolyl carboxamides as CRAC channel inhibitors | GLAXO GROUP LIMITED (GB) | 2013-03-19 | — | — | US | disclosed |
| US-20120053150-A1 | N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS | GLAXO GROUP LIMITED (GB) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053150-A1 | N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS | ORAI1, TRPV1, CACNA1E | CACNA1I 18/4885CACNA1G 20/4885CACNA1H 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.